share price, page-340

First 340 Last

Share
Profile

Follow
reg

598 Posts.

52

13/06/19

14:10

Post #: 39041665
Share

Originally posted by Vmk Research ↑

Hi Dwhale and reg,

We would all like as much data as possible. Wouldn't it be great to sit at the table with management and see their management reports and operating metrics? Unfortunately we have to do our detective work with the public information we have in front of us. However 2 points. Even though you cannot ask for numbers that are not in the public domain, you can ask the management what operating metrics they use and what they look at, as a way of assessing whether you like the way management are looking at things.

Both DH and Reg want their management team to focus on gross churn, right down to a very granular level. How many customers have reduced seats and how many customers have increased seats? What is X, the total number of seats added by existing customers? and what is Y, the total number of seats reduced by existing customers? We know that X is greater than Y (negative net churn) but do management have the breakdown of the numbers at their finger tips. We cant ask them for the number but we can ask them if it is a metric they follow. You will be shocked at how few managers will know (our former gym CEO being a case in point). It is a fair question to ask the new CFO. He has been brought in as a gnarly numbers guy! At the moment, all we know is that X is > Y but you are correct, we dont know what Y is. Some companies dont even know.

Expand

Hi vmk

I've probably been a bit clumsy in the way I've expressed it, but I don't want management to focus on gross churn. Just a broad brushstroke is good.

Opening ARR
+ New business
+ Net upsell
- Churn
= Closing ARR

If churn contains something of note, give us a bit of context. We can then track over time.
I like simple metrics, I'm a simple bloke.

LVT Price at posting: 44.0¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

PL3

Patagonia looks to raise $2.15M for South American exploration and development

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

There are more pages in this discussion • 71 more messages in this thread...

First 340 Last

Add LVT (ASX) to my watchlist

(20min delay)
Last 0.6¢		Change 0.000(0.00%)		Mkt cap ! $6.474M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

share price, page-340

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Patagonia looks to raise $2.15M for South American exploration and development

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Featured News

Featured News

share price, page-340

Top Stories

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Patagonia looks to raise $2.15M for South American exploration and development

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Featured News

Featured News